Gleanboots Life Science Private Limited
About Gleanboots Life Science Private Limited
Data last updated:
Gleanboots Life Science Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 October 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1999PTC101791. Its GSTIN is 09AACCP9383Q2ZD (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It was formerly known as Pol Pharma (India) Private Limited. It is led by directors Harsh Kansal and Yogesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1725/14 Iiird Floor Ram Gali Bhagirath Place Chandni Chowk, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.72 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹72,099 (net margin 0.4%) and EBITDA of ₹1.56 Lakh (EBITDA margin 0.9%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gleanboots Life Science Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1725/14 Iiird Floor Ram Gali Bhagirath Place Chandni Chowk, Delhi, India – 110006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gleanboots Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gleanboots Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gleanboots Life Science Private Limited, buy the company report.
Financials of Gleanboots Life Science Private Limited
FY 2025 filings availableGleanboots Life Science Private Limited reported revenue of ₹1.72 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 24% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA rose 116% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72,099 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gleanboots Life Science Private Limited, buy the company report.
Board of directors of Gleanboots Life Science Private Limited
Gleanboots Life Science has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harsh Kansal | Director | 14 Mar 2017 | 9 Years 7 Months | Current |
| Yogesh Kumar Also directs: Agnishakti Tactical Systems LLP | Director | 01 Dec 2014 | 11 Years 11 Months | Current |
Auditor
Gleanboots Life Science Private Limited is audited by PRAVEEN KUMAR GOEL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAVEEN KUMAR GOEL & ASSOCIATES | FY 2023 | 002977C |
Shareholding
The shareholding of Gleanboots Life Science Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gleanboots Life Science Private Limited, buy the company report.
Legal cases
Gleanboots Life Science Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Wockhardt Limited | Disposed |
| Bombay High Court | Court case (NMCD) | Filed against the company by Wockhardt Limited | Disposed |
To see the full case history of Gleanboots Life Science Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gleanboots Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gleanboots Life Science has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCP9383Q2ZD | Uttar Pradesh | Active | 05 Feb 2021 |
To see the full GST registrations and return filing status of Gleanboots Life Science Private Limited, buy the company report.
Recent activity
Gleanboots Life Science Private Limited has 10 board changes on record since 2007: 6 appointments and 4 cessations. The latest: Ranjeet Singh ceased to be Director on 10 Aug 2017.
1 earlier event is in the company report.
Frequently asked questions
Gleanboots Life Science is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 October 1999 (27+ years old) and is registered under CIN U24239DL1999PTC101791.
Gleanboots Life Science has 2 current directors:
- Harsh Kansal - Director
- Yogesh Kumar - Director
The latest financial statements of Gleanboots Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gleanboots Life Science is 09AACCP9383Q2ZD, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Gleanboots Life Science is U24239DL1999PTC101791. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gleanboots Life Science has 2 court cases on record: 2 filed against it.
Gleanboots Life Science was incorporated on 01 October 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.
Ranjeet Singh ceased to be Director on 10 Aug 2017. Harsh Kansal was appointed as Director on 14 Mar 2017. Rajiv Garg ceased to be Director on 08 Jul 2015. Gleanboots Life Science has 10 board changes on record in total.
The registered office of Gleanboots Life Science is at 172514 Iiird Floor Ram Gali Bhagirath Place Chandni Chowk, Delhi, India – 110006.
Gleanboots Life Science operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
